» Articles » PMID: 23319969

Lyme Disease: Review

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2013 Jan 16
PMID 23319969
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Lyme disease is a multi-organ animal-borne disease, caused by spirochetes of Borrelia burgdorferi (Bb), which typically affect the skin, nervous system, musculoskeletal system and heart. A history of confirmed exposure to tick bites, typical signs and symptoms of Lyme borreliosis and positive tests for anti-Bb antibodies, are the basis of a diagnosis. A two-step diagnosis is necessary: the first step is based on a high sensitivity ELISA test with positive results confirmed by a more specific Western blot assay. Antibiotic therapy is curative in most cases, but some patients develop chronic symptoms, which do not respond to antibiotics. The aim of this review is to summarize our current knowledge of the symptoms, clinical diagnosis and treatment of Lyme borreliosis.

Citing Articles

Diagnostic Challenges of Lyme Co-infections: Lessons From a Lyme and Herpes Simplex Virus-1 (HSV-1) Cocktail.

Bhatia M, Abdelbaky M, Lahoti L Cureus. 2024; 16(5):e60213.

PMID: 38868243 PMC: 11167585. DOI: 10.7759/cureus.60213.


Case presentation and management of Lyme disease patients: a 9-year retrospective analysis in France.

Perthame E, Chartier L, George J, Varloud M, Ferquel E, Choumet V Front Med (Lausanne). 2024; 10:1296486.

PMID: 38298513 PMC: 10829333. DOI: 10.3389/fmed.2023.1296486.


Trained immunity: A "new" weapon in the fight against infectious diseases.

Dagenais A, Villalba-Guerrero C, Olivier M Front Immunol. 2023; 14:1147476.

PMID: 36993966 PMC: 10040606. DOI: 10.3389/fimmu.2023.1147476.


Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium.

Willems R, Verhaeghe N, Perronne C, Borgermans L, Annemans L Eur J Public Health. 2023; 33(4):668-674.

PMID: 36972275 PMC: 10393486. DOI: 10.1093/eurpub/ckad045.


Musculoskeletal manifestations of Lyme borreliosis - a review.

Udziela S, Biesiada G, Osiewicz M, Michalak M, Stazyk K, Garlicki A Arch Med Sci. 2022; 18(3):726-731.

PMID: 35591816 PMC: 9102650. DOI: 10.5114/aoms.2020.96458.


References
1.
Wormser G, Dattwyler R, Shapiro E, Halperin J, Steere A, Klempner M . The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006; 43(9):1089-134. DOI: 10.1086/508667. View

2.
Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Moniuszko A . [Articular symptoms in Lyme borreliosis]. Pol Merkur Lekarski. 2008; 24(144):542-4. View

3.
Derdakova M, Lencakova D . Association of genetic variability within the Borrelia burgdorferi sensu lato with the ecology, epidemiology of Lyme borreliosis in Europe. Ann Agric Environ Med. 2006; 12(2):165-72. View

4.
Klempner M, Hu L, Evans J, Schmid C, JOHNSON G, Trevino R . Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001; 345(2):85-92. DOI: 10.1056/NEJM200107123450202. View

5.
Flisiak R, Pancewicz S . [Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases]. Przegl Epidemiol. 2008; 62(1):193-9. View